These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2305013)

  • 21. Rats with scopolamine- or MK-801-induced spatial discrimination deficits in the cone field task: animal models for impaired spatial orientation performance.
    Bouger PC; van der Staay FJ
    Eur Neuropsychopharmacol; 2005 May; 15(3):331-46. PubMed ID: 15820423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-related decline in central cholinergic function demonstrated with scopolamine.
    Tariot PN; Patel SV; Cox C; Henderson RE
    Psychopharmacology (Berl); 1996 May; 125(1):50-6. PubMed ID: 8724448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of a confectionery snack on attention in young boys.
    Busch CR; Taylor HA; Kanarek RB; Holcomb PJ
    Physiol Behav; 2002 Nov; 77(2-3):333-40. PubMed ID: 12419410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans.
    Ellis JR; Ellis KA; Bartholomeusz CF; Harrison BJ; Wesnes KA; Erskine FF; Vitetta L; Nathan PJ
    Int J Neuropsychopharmacol; 2006 Apr; 9(2):175-89. PubMed ID: 15877932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.
    Ghoneim MM; Mewaldt SP
    Psychopharmacology (Berl); 1977 Mar; 52(1):1-6. PubMed ID: 403551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties.
    Kennedy DO; Wake G; Savelev S; Tildesley NT; Perry EK; Wesnes KA; Scholey AB
    Neuropsychopharmacology; 2003 Oct; 28(10):1871-81. PubMed ID: 12888775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of acute scopolamine in geriatric depression.
    Newhouse PA; Sunderland T; Tariot PN; Weingartner H; Thompson K; Mellow AM; Cohen RM; Murphy DL
    Arch Gen Psychiatry; 1988 Oct; 45(10):906-12. PubMed ID: 3048225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scopolamine challenges in Alzheimer's disease.
    Sunderland T; Tariot P; Murphy DL; Weingartner H; Mueller EA; Cohen RM
    Psychopharmacology (Berl); 1985; 87(2):247-9. PubMed ID: 3931154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults.
    Thomas E; Snyder PJ; Pietrzak RH; Jackson CE; Bednar M; Maruff P
    Neuropsychologia; 2008 Aug; 46(10):2476-84. PubMed ID: 18514746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral scopolamine on human stimulus evaluation.
    Callaway E; Halliday R; Naylor H; Schechter G
    Psychopharmacology (Berl); 1985; 85(2):133-8. PubMed ID: 3925478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man.
    Nuotto E
    Eur J Clin Pharmacol; 1983; 24(5):603-9. PubMed ID: 6873137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers.
    Wezenberg E; Verkes RJ; Ruigt GS; Hulstijn W; Sabbe BG
    Neuropsychopharmacology; 2007 Jun; 32(6):1272-83. PubMed ID: 17119538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.
    Ye JW; Cai JX; Wang LM; Tang XC
    J Pharmacol Exp Ther; 1999 Feb; 288(2):814-9. PubMed ID: 9918593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
    Curran HV; Schifano F; Lader M
    Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scopolamine impairs spatial working memory in the radial maze: an analysis by error type and arm choice.
    Pilcher JJ; Sessions GR; McBride SA
    Pharmacol Biochem Behav; 1997 Oct; 58(2):449-59. PubMed ID: 9300605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.
    Sunderland T; Tariot PN; Cohen RM; Weingartner H; Mueller EA; Murphy DL
    Arch Gen Psychiatry; 1987 May; 44(5):418-26. PubMed ID: 3579494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects.
    Parrott AC; Wesnes K
    Psychopharmacology (Berl); 1987; 92(4):513-9. PubMed ID: 3114803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive and behavioral effects of cholinergic, dopaminergic, and serotonergic blockade in humans.
    Vitiello B; Martin A; Hill J; Mack C; Molchan S; Martinez R; Murphy DL; Sunderland T
    Neuropsychopharmacology; 1997 Jan; 16(1):15-24. PubMed ID: 8981385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task.
    Azmi N; Norman C; Spicer CH; Bennett GW
    Behav Pharmacol; 2006 Jun; 17(4):357-62. PubMed ID: 16914954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen and the cholinergic system modulate visuospatial attention in monkeys (Macaca fascicularis).
    Voytko ML
    Behav Neurosci; 2002 Apr; 116(2):187-97. PubMed ID: 11996304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.